These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15190273)

  • 1. Treatment of venous thromboembolism: duration and new options.
    Huisman MV
    Hematol J; 2004; 5 Suppl 3():S24-8. PubMed ID: 15190273
    [No Abstract]   [Full Text] [Related]  

  • 2. Perioperative bridging with fondaparinux in a woman with antithrombin deficiency.
    Bauersachs R; Alban S
    Thromb Haemost; 2007 Mar; 97(3):498-9. PubMed ID: 17334522
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials of new anticoagulants.
    Anderson J; O'Donnell M
    Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New anticoagulants for the prevention and treatment of venous thromboembolism.
    McRae SJ; Ginsberg JS
    Vasc Health Risk Manag; 2005; 1(1):41-53. PubMed ID: 17319097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents.
    Iorio A
    J Thromb Haemost; 2004 Jul; 2(7):1055-7. PubMed ID: 15219186
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
    Nielsen JD
    Ugeskr Laeger; 2005 May; 167(21):2261-5. PubMed ID: 15962850
    [No Abstract]   [Full Text] [Related]  

  • 7. [New discoveries in the treatment of deep venous thrombosis: length of the treatment is the target of international studies].
    Berntorp E
    Lakartidningen; 1999 Nov; 96(45):4892-4. PubMed ID: 10596525
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment and prevention of venous thromboembolic events: present and future antithrombotic agents].
    Drouet L
    Bull Acad Natl Med; 2003; 187(1):85-96; discussion 96-7. PubMed ID: 14556456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New anticoagulants -- their clinical significance].
    Haas S
    Ther Umsch; 2003 Jan; 60(1):19-23. PubMed ID: 12638473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of fondaparinux for the prevention and treatment of venous thromboembolism.
    Turpie AG
    Expert Opin Drug Saf; 2005 Jul; 4(4):707-21. PubMed ID: 16011449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism.
    Blann AD; Lip GY
    BMJ; 2006 Jan; 332(7535):215-9. PubMed ID: 16439400
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prophylaxis and treatment of venous thromboembolism: the role of new antithrombotic drugs].
    Falciani M; Imberti D; Prisco D
    Recenti Prog Med; 2005 Apr; 96(4):196-204. PubMed ID: 15932039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New anticoagulants for treatment of venous thromboembolism.
    Weitz JI
    Circulation; 2004 Aug; 110(9 Suppl 1):I19-26. PubMed ID: 15339877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term anticoagulation of idiopathic venous thromboembolism: do we have the answers?
    Goldhaber S
    Clin Adv Hematol Oncol; 2003 May; 1(5):276-7. PubMed ID: 16224420
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
    Ageno W; Squizzato A
    Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
    [No Abstract]   [Full Text] [Related]  

  • 16. [Duration of oral anticoagulant therapy in venous thromboembolism].
    Pinède L
    Rev Med Interne; 2001 Dec; 22(12):1225-36. PubMed ID: 11794893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of anticoagulation after first episode of unprovoked venous thromboembolism.
    Abdel-Razeq HN; Radwi GR
    Saudi Med J; 2004 Nov; 25(11):1776; author reply 1776-7. PubMed ID: 15573235
    [No Abstract]   [Full Text] [Related]  

  • 18. [New antithrombotic agents. Towards a new therapeutic plan].
    Fiessinger JN
    Rev Prat; 2003 May; 53(10):1063-4. PubMed ID: 12846024
    [No Abstract]   [Full Text] [Related]  

  • 19. [New anticoagulants in the treatment of venous thrombo-embolic disease].
    Bura-Riviere A; Fiessinger JN
    Rev Med Interne; 2003 Nov; 24(11):738-44. PubMed ID: 14604751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter 1: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Wille-Jorgensen P
    Br J Surg; 2006 Mar; 93(3):374; author reply 375-6. PubMed ID: 16498577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.